Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsuko Hachiya

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|June 23, 2016
Rilpivirine resistance mutation E138K in HIV-1 reverse transcriptase predisposed by prevalent polymorphic mutationsTsunefusa Hayashida, Atsuko Hachiya, Hirotaka Ode, et al.
Virology|September 8, 2004
Novel patterns of nevirapine resistance-associated mutations of human immunodeficiency virus type 1 in treatment-naïve patientsAtsuko Hachiya, Hiroyuki Gatanaga, Eiichi Kodama, et al.
The Journal of Biological Chemistry|September 30, 2010
The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapineMatthew M Schuckmann, Bruno Marchand, Atsuko Hachiya, et al.
Frontiers in Microbiology|December 1, 2015
Quasispecies Analyses of the HIV-1 Near-full-length Genome With Illumina MiSeqHirotaka Ode, Masakazu Matsuda, Kazuhiro Matsuoka, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 2021
Specific mutations in the HIV-1 G-tract of the 3'-polypurine tract cause resistance to integrase strand transfer inhibitorsAtsuko Hachiya, Mai Kubota, Urara Shigemi, et al.
Journal of Medical Virology|July 27, 2016
Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, ZimbabweIan Baudi, Sayuki Iijima, Nyasha Chin'ombe, et al.
Antiviral Research|May 10, 2015
Natural polymorphism S119R of HIV-1 integrase enhances primary INSTI resistanceAtsuko Hachiya, Hirotaka Ode, Masakazu Matsuda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2013
Naturally selected rilpivirine-resistant HIV-1 variants by host cellular immunityHiroyuki Gatanaga, Hayato Murakoshi, Atsuko Hachiya, et al.
The International Journal of Biochemistry & Cell Biology|April 26, 2012
Antiviral therapies: focus on hepatitis B reverse transcriptaseEleftherios Michailidis, Karen A Kirby, Atsuko Hachiya, et al.
Journal of Virology|January 25, 2008
Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitorsAtsuko Hachiya, Eiichi N Kodama, Stefan G Sarafianos, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|June 23, 2016
Rilpivirine resistance mutation E138K in HIV-1 reverse transcriptase predisposed by prevalent polymorphic mutationsTsunefusa Hayashida, Atsuko Hachiya, Hirotaka Ode, et al.
Virology|September 8, 2004
Novel patterns of nevirapine resistance-associated mutations of human immunodeficiency virus type 1 in treatment-naïve patientsAtsuko Hachiya, Hiroyuki Gatanaga, Eiichi Kodama, et al.
The Journal of Biological Chemistry|September 30, 2010
The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapineMatthew M Schuckmann, Bruno Marchand, Atsuko Hachiya, et al.
Frontiers in Microbiology|December 1, 2015
Quasispecies Analyses of the HIV-1 Near-full-length Genome With Illumina MiSeqHirotaka Ode, Masakazu Matsuda, Kazuhiro Matsuoka, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 2021
Specific mutations in the HIV-1 G-tract of the 3'-polypurine tract cause resistance to integrase strand transfer inhibitorsAtsuko Hachiya, Mai Kubota, Urara Shigemi, et al.
Journal of Medical Virology|July 27, 2016
Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, ZimbabweIan Baudi, Sayuki Iijima, Nyasha Chin'ombe, et al.
Antiviral Research|May 10, 2015
Natural polymorphism S119R of HIV-1 integrase enhances primary INSTI resistanceAtsuko Hachiya, Hirotaka Ode, Masakazu Matsuda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2013
Naturally selected rilpivirine-resistant HIV-1 variants by host cellular immunityHiroyuki Gatanaga, Hayato Murakoshi, Atsuko Hachiya, et al.
The International Journal of Biochemistry & Cell Biology|April 26, 2012
Antiviral therapies: focus on hepatitis B reverse transcriptaseEleftherios Michailidis, Karen A Kirby, Atsuko Hachiya, et al.
Journal of Virology|January 25, 2008
Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitorsAtsuko Hachiya, Eiichi N Kodama, Stefan G Sarafianos, et al.
Pageof 6